Лечение злокачественных новообразований на фоне беременности. Часть 1 (общие вопросы)

Лечение злокачественных новообразований на фоне беременности. Часть 1 (общие вопросы)

Автор: Паньшин Георгий Александрович, Слобина Елена Леонидовна

Журнал: Вестник Российского научного центра рентгенорадиологии Минздрава России @vestnik-rncrr

Рубрика: Обзоры

Статья в выпуске: 3 т.15, 2015 года.

Бесплатный доступ

В статье представлен краткий обзор возможностей проведения современного специального противоопухолевого лечения злокачественных новообразований у беременных женщин и освещены наиболее важные стратегические вопросы, связанные с определением оптимальной терапевтической тактики у данного контингента онкологических больных.

Рак и беременность, противоопухолевое лечение

Короткий адрес: https://sciup.org/14955491

IDR: 14955491

Список литературы Лечение злокачественных новообразований на фоне беременности. Часть 1 (общие вопросы)

  • А.Г. Кедрова, С.А. Леваков. Онкологические заболевания у беременных. Современная тактика и основные трудности. Клиническая практика. 2014. № 3. С. 43-50.
  • Бохман Я.В. Лекции по онкогинекологии. Москва: Медицинское информационное агентство. 2007. С.78-92.
  • В. Паукер. Онкологические заболевания и беременность. Онкогинекология 2014. № 4. С. 59-67.
  • Вишневская Е.Е. Рак и беременность. Минск: Вышейшая школа, 2000. 319 с.
  • Волочаева М.В., Шмаков Р.Г. Беременность и рак молочной железы: тактика ведения беременности, особенности диагностики лечения. Эффективная фармакотерапия. Акушерство и гинекология. 2013 №3 (28). http://umedp.ru/articles/beremennost_i_rak_molochnoy_zhelezy_taktika_vedeniya_beremennost i_osobennosti_diagnostiki_i_lecheniya.html
  • Параконная А.А. Дис. докт. мед. наук/Москва. 2009. 292 с.
  • Параконная А.А. Рак молочной железы и беременность. The Jourmal Malignant tumors (русскоязычное издательство журнала «Злокачественные опухоли». 2012. Т. 2. № 1. С. 714.
  • Урманчеева А.Ф. Рак шейки матки и беременность. Практическая онкология. 2002. Т. 3. № 3. С. 183-193.
  • Alexander A., Samlowski W.E., Grossman D., et al. Metastatic melanoma in pregnancy: risk of transplacental metastases in the infant. J Clin Oncol. 2003. V. 21. P. 2179-2186.
  • Amant F., Van Calsteren K., Halaska M.J., et al. Gynecologic cancers in pregnancy: guidelines of an international consensus meeting. Int J Gynecol Cancer. 2009. V. 19 (Suppl 1). S1-S12.
  • American Cancer Society: Cancer Facts and Figures 2009. Atlanta, Ga: American Cancer Society, 2009.
  • Avilés A., Neri N. Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero. Clin Lymphoma. 2001. V. 2. P. 173-177.
  • Avilés A., Neri N., Nambo M.J. Long-term evaluation of cardiac function in children who received anthracyclines during pregnancy. Ann Oncol. 2006. V. 7. P. 286-288.
  • Azim HA Jr, Azim H, Peccatori FA. Treatment of cancer during pregnancy with monoclonal antibodies: a real challenge. Expert Rev. Clin. Immunol. 2010. V. 6. No. 6. P. 821-826.
  • Azim Jr. H.A., Peccatori F.A., Liptrott S.J., et al. Breast cancer and pregnancy: how safe is trastuzumab? Nat Rev Clin Oncol. 2009. V. 6. No. 6. P. 367-370.
  • Azim H.A. Jr., Peccatori F.A. Treatment of cancer during pregnancy: the need for tailored strategies. J. Clin. Oncol. 2010. V. 28. No. 18, e302-e304.
  • Azim H.A. Jr., Peccatori F.A., Pavlidis N. Treatment of the pregnant mother with cancer: a systematic review on the use of cytotoxic, endocrine, targeted agents and immunotherapy during pregnancy. Part I: solid tumors. Cancer Treat Rev. 2010a. V. 36. No. 2. S. 101-109.
  • Azim H.A. Jr., Peccatori F.A., Pavlidis N. Treatment of the pregnant mother with cancer: a systematic review on the use of cytotoxic, endocrine, targeted agents and immunotherapy during pregnancy. Part II: hematological tumors. Cancer Treat Rev. 2010b. V. 36. No. 2. S. 110-121.
  • Beale J.M., Tuohy J., McDowell S.J. Herceptin (trastuzumab) therapy in a twin pregnancy with associated oligohydramnios. Am J Obstet Gynecol. 2009. V. 201. No. 1, e13-14.
  • Berveiller P., Mir O., Sauvanet E., et al. Ectopic pregnancy in a breast cancer patient receiving trastuzumab. Reprod Toxicol. 2008. V. 25. No 2. P. 286-288.
  • Byrd B.F.Jr., Bayer D.S., Robertson J.C., Stephenson S.E.Jr. Treatment of breast tumors associated with pregnancy and lactation. Ann Surg. 1962. V. 155. Р. 940-947.
  • Cancer During Pregnancy. Approved by the Cancer.Net Editorial Board, 01/2013. URL http://www.cancer.net/coping-and-emotions/sexual-and-reproductive-health/cancer-during-pregnancy (дата обращения 20.07.2015).
  • Cardonick E., Iacobucci A. Use of chemotherapy during human pregnancy. Lancet Oncol. 2004. V. 5. No. 5. P. 283-291.
  • Cohen-Kerem R., Railton C., Oren D., et al. Pregnancy outcome following non-obstetric surgical intervention. Am J Surg. 2005. V. 190. P. 467-473.
  • Duncan P.G., Pope W.D., Cohen M.M., et al. Fetal risk of anesthesia and surgery during pregnancy. Anesthesiology. 1986. V. 64. P. 790-794.
  • Eheman C., Henley S.J., Ballard-Barbash R., et al. Annual Report to the Nation on the status of cancer, 1975-2008, featuring cancers associated with excess weight and lack of sufficient physical activity. Cancer. 2012. V. 118. P. 2338-2366.
  • Lundqvist E.Â. Principles of chemotherapy. International Journal of Gynecology & Obstetrics. FIGO Cancer Report 2012. S151-S154.
  • ESMO 2014. Press Releas: Cancer During Pregnancy: Chemotherapy and Radiotherapy are Safe for Babies, Stadies Show. URL http://www.esmo.org/Conferences/Past-ConferencesÆSMQ-2014-Congress/Press-Media/Cancer-During-Pregnancy-Chemotherapy-and-Radiotherapy-are-Safe-for-Babies-Studies-Show (дата обращения 20.07.2015).
  • Fenig E., Mishaeli M., Kalish Y. et al. Pregnancy and radiation. Cancer Treat Review. 2001. V. 27. P. 1-7.
  • Gailmberti V., Clocca M., Leonard M.C., et al. Is electron beam intraoperative radiotherapy (ELIOT) safe in pregnanty women with early breast cancer? In vivo dosimetry to assess fetal dose. Ann Surg Oncol. 2009. V. 16. No. 1. P. 100-105.
  • Germann N., Goffinet F., Goldwasser F. Anthracyclines during pregnancy: embryo-fetal outcome in 160 patients. Ann Oncol. 2004. V. 15. P.146-150.
  • Gustavson K.H., Jagell S., Blomquist H.K., et al. Microcephaly, mental retardation and chromosomal aberrations in a girl following radiation therapy during late fetal life. Acta Radiol Oncol. 1981. V. 20. P. 209-212.
  • International Commission on Radiological Protection. Biological effects after prenatal irradiation (embryo, foetus). Annals of the ICRP. 2003. V. 33. No. 1-2. P. 5-206.
  • Van Calsteren K., Amant F. Chemotherapy during pregnancy: pharmacokinetics and impact on foetal neurological development. Verh K Acad Geneeskd Belg. 2010. V. 2. No. 4. P. 278-286.
  • Kal H.B., Struikmans H. Radiotherapy during pregnancy: fact and fiction. Lancet Oncol. 2005. V. 6. No 5. P. 328-333.
  • Roszkowski K., Basta P. Tangential radiotherapy and electron beam intraoperative radiotherapy in pregnancy associated breast cancer. Archives of Perinatal Medicine. 2013. V. 19. No. 4. P. 187-190.
  • Lawrenz B., Henes M., Neunhoeffer E., et al. Pregnancy after successful cancer treatment: what needs to be considered. Onkologie. 2012. V. 35. P. 128-132.
  • Luis S.A., Christie D.R., Kaminski A., et al. Pregnancy and radiotherapy: management options for minimising risk, case series and comprehensive literature review. J Med Imaging Radiat Oncol. 2009. V. 53. No. 6. P. 559-568.
  • Mathevet P., Nessah K., Dargent D., et al. Laparoscopic management of adnexal masses in pregnancy: a case series. Eur J Obstet Gynecol Reprod Biol. 2003. V. 108. P. 217-222.
  • Meyer-Wittkopf M., Barth H., Emons G., Schmidt S. Fetal cardiac effects of doxorubicin therapy for carcinoma of the breast during pregnancy: case report and review of the literature. Ultrasound Obstet Gynecol. 2001. V. 18. P. 62-66.
  • Mieog J.S., van der Hage J.A., van de Veidg C.J. Neoadjuvant chemotherapy for operable breast cancer. Br J Surg. 2007. V. 94. P. 1189-1120.
  • Moran B.J., Yano H., Al Zahir N., et al. Conflicting priorities in surgical intervention for cancer in pregnancy. Lancet Oncol. 2007. V. 8. No. 536-544.
  • Morice P., Uzan C., Gouy S., et al. Gynaecological cancers in pregnancy. Lancet. 2012. V. 379. No. 9815. P. 558-569.
  • Ni Mhuireachtaigh R., O’Gorman D.A. Anesthesia in pregnant patients for nonobstetric surgery. J Clin Anesth. 2006. V. 18. P. 60-66.
  • Nulman I., Laslo D., Fried S., et al. Neurodevelopment of children exposed in utero to treatment of maternal malignancy. Br J Cancer. 2001. V. 85. P. 1611-1618.
  • Mir O., Berveiller P., Ropert S., et al. Use of platinum derivatives during pregnancy. Cancer. 2008. V. 113, No. 11. P. 3069-3074.
  • Pavlidis N.A. Coexistence of pregnancy and malignancy. Oncologist. 2002. V. 7. No. 4. P. 279-287.
  • Basta P., Bak A., Roszkowski K. Cancer treatment in pregnant women. Contemp Oncol (Pozn). 2014. V. 18. No 1. P. 1-7.
  • Peccatori F.A., Azim H.A. Jr., Orecchia R., et al. Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013. V. 24 Suppl 6: vi160-70.
  • Peccatori F., Martinelli G., Gentilini O., Goldhirsch A. Chemotherapy during pregnancy: what is really safe? Lancet Oncol. 2004. V. 5. No. 7. P. 398.
  • Pentheroudakis G., Pavlidis N. Cancer and pregnancy: poena magna, not anymore. Eur J Cancer. 2006. V. 42. No. 2. P. 126-140.
  • Pentheroudakis G. Cancer and pregnancy. Annals of Oncology. 2008. V. 19 (Suppl.5). Р. 38-39.
  • Pentheroudakis G., Orecchia R., Hoekstra H.J., et al. ESMO GuidelinesWorking Group. Cancer, fertility and pregnancy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010. V. 21 (Suppl 5):v266-273.
  • Robinson A.A., Watson W.J., Leslie K.K. Targeted treatment using monoclonal antibodies and tyrosine-kinase inhibitorsin pregnancy. Lancet Oncol. 2007. V. 8. No. 8. P. 738-743.
  • Smith L.H., Dalrymple J.L., Leiserowitz G.S., et al. Obstetrical deliveries associated with maternal malignancy in California, 1992 through 1997. Am J Obstet Gynecol. 2001. V. 184. P. 1504-1513.
  • Stenshheim H., Moller B., van Dijk T., et al. Cause specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study. J Clin Oncol. 2009. V. 27. P. 45-51.
  • Stovall M., Blackwell C.R., Cundiff J., et al. Fetal dose from radiotherapy with photon beams: report of AAPM. Radiation Therapy Committee Task Group No. 36. Medical Physics. 1995. V. 22. No. 1. P. 63-82.
  • Shrim A., Garcia-Bournissen F., Maxwell C., et al. Favorable pregnancy outcome following trastuzumab (herceptin) use during pregnancy -case report and updated literature review. Reprod Toxicol. 2007. V. 23. No. 4. P. 611-613.
  • Van Calsteren K., Heyns L., De Smet F. et al. Cancer during pregnancy: An analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes. J Clin Oncol. 2010. V. 28. P. 683-689.
  • Voulgaris E., Pentheroudakis G., Pavlidis N. Cancer and pregnancy: a comprehensive review. Surg Oncol. 2011. V. 20: e175-185.
  • Waterston A.M., Graham J. Effect of adjuvant trastuzumab on pregnancy. J Clin Oncol. 2006. V. 24. No. 2. P. 321-322.
  • Watson W.J. Herceptin (trastuzumab) therapy during pregnancy: association with reversible anhydramnios. Obstet Gynecol. 2005. V. 105. No. 3. P. 642-643.
  • Weber-Schoendorfer C., Schaefer C. Trastuzumab exposure during pregnancy. Reprod Toxicol. 2008. V. 25. P. 390-391.
  • Witzel I.D., Muller V., Harps E., et al. Trastuzumab in pregnancy associated with poor fetal outcome. Ann Oncol. 2008. V. 19. No. 1. P. 191-192.
  • Yuen P.M., Ng P.S., Leung P.L., Rogers M.S. Outcome in laparoscopic management of persistent adnexal mass during the second trimester of pregnancy. Surg Endosc. 2004. V. 18. P. 1354-1357.
Еще
Статья научная
QR-код для установки приложения SciUp Наведите камеру и скачайте бесплатное приложение SciUp